These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9684729)

  • 21. Fibrin gel structure and clotting time.
    Blombäck B; Okada M
    Thromb Res; 1982 Jan 1-15; 25(1-2):51-70. PubMed ID: 6121390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factor XIIIa-catalyzed coupling of structural proteins.
    Kahn DR; Cohen I
    Biochim Biophys Acta; 1981 May; 668(3):490-4. PubMed ID: 6113010
    [No Abstract]   [Full Text] [Related]  

  • 23. Factor XIIIa cross-links lipoprotein(a) with fibrinogen and is present in human atherosclerotic lesions.
    Romanic AM; Arleth AJ; Willette RN; Ohlstein EH
    Circ Res; 1998 Aug; 83(3):264-9. PubMed ID: 9710118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rheological characterization and dissolution kinetics of fibrin gels crosslinked by a microbial transglutaminase.
    Sun Y; Giraudier O; Garde VL
    Biopolymers; 2005 Apr; 77(5):257-63. PubMed ID: 15700298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substrate-bound fibrinogen, fibrin and other cell attachment-promoting proteins as a scaffold for cultured vascular smooth muscle cells.
    Naito M; Funaki C; Hayashi T; Yamada K; Asai K; Yoshimine N; Kuzuya F
    Atherosclerosis; 1992 Oct; 96(2-3):227-34. PubMed ID: 1281631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of smooth muscle cell behaviour by platelet-derived factors and the extracellular matrix.
    Wren FE; Schor AM; Schor SL; Grant ME
    J Cell Physiol; 1986 May; 127(2):297-302. PubMed ID: 3700485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fine-tuning of a three-dimensional microcarrier-based angiogenesis assay for the analysis of endothelial-mesenchymal cell co-cultures in fibrin and collagen gels.
    Dietrich F; Lelkes PI
    Angiogenesis; 2006; 9(3):111-25. PubMed ID: 17051343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crosslinking kinetics of the human transglutaminase, factor XIII[A2], acting on fibrin gels and gamma-chain peptides.
    Lewis KB; Teller DC; Fry J; Lasser GW; Bishop PD
    Biochemistry; 1997 Feb; 36(5):995-1002. PubMed ID: 9033388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cigarette smoke contains anticoagulants against fibrin aggregation and factor XIIIa in plasma.
    Galanakis DK; Laurent P; Janoff A
    Science; 1982 Aug; 217(4560):642-5. PubMed ID: 6124042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roles of genipin crosslinking and biomolecule conditioning in collagen-based biopolymer: Potential for vascular media regeneration.
    Madhavan K; Belchenko D; Tan W
    J Biomed Mater Res A; 2011 Apr; 97(1):16-26. PubMed ID: 21308981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The covalent structure of factor XIIIa crosslinked fibrinogen fibrils.
    Mosesson MW; Siebenlist KR; Hainfeld JF; Wall JS
    J Struct Biol; 1995; 115(1):88-101. PubMed ID: 7577232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Smooth muscle cell adhesion on crosslinked hyaluronan gels.
    Ramamurthi A; Vesely I
    J Biomed Mater Res; 2002 Apr; 60(1):195-205. PubMed ID: 11835176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of alpha5beta1 and alphavbeta3 integrins on smooth muscle cell spreading and migration in fibrin gels.
    Ikari Y; Yee KO; Schwartz SM
    Thromb Haemost; 2000 Oct; 84(4):701-5. PubMed ID: 11057873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factor XIIIa supports microvascular endothelial cell adhesion and inhibits capillary tube formation in fibrin.
    Dallabrida SM; Falls LA; Farrell DH
    Blood; 2000 Apr; 95(8):2586-92. PubMed ID: 10753838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crosslinking of soluble fibrin and fibrinogen.
    Selmayr E; Mahn I; Müller-Berghaus G
    Thromb Res; 1985 Aug; 39(4):467-74. PubMed ID: 2864751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid detection of cross-linked fibrin degradation products in plasma using monoclonal antibody-coated latex particles.
    Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN
    Am J Clin Pathol; 1986 Mar; 85(3):360-4. PubMed ID: 2875646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the factors contributing to fibrin-dependent plasminogen activation.
    Mosesson MW; Siebenlist KR; Voskuilen M; Nieuwenhuizen W
    Thromb Haemost; 1998 Apr; 79(4):796-801. PubMed ID: 9569195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The contribution of activated factor XIII to fibrinolytic resistance in experimental pulmonary embolism.
    Reed GL; Houng AK
    Circulation; 1999 Jan; 99(2):299-304. PubMed ID: 9892598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Un-cross-linked fibrin substrates inhibit keratinocyte spreading and replication: correction with fibronectin and factor XIII cross-linking.
    Weiss E; Yamaguchi Y; Falabella A; Crane S; Tokuda Y; Falanga V
    J Cell Physiol; 1998 Jan; 174(1):58-65. PubMed ID: 9397156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of cross-linking on clearance of circulating alpha-fibrin monomer and its complexes.
    Shainoff JR; Dardik BN
    J Lab Clin Med; 1990 Mar; 115(3):314-23. PubMed ID: 1968950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.